메뉴 건너뛰기




Volumn 36, Issue 4, 2009, Pages 1212-1218

Accuracy of two simple methods for estimation of thyroidal I 131 kinetics for dosimetry-based treatment of Graves' disease

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; DIAGNOSIS; DOSIMETRY; KINETICS; PATIENT TREATMENT;

EID: 63849099765     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3093237     Document Type: Article
Times cited : (14)

References (12)
  • 1
    • 0028929516 scopus 로고
    • Radioiodine therapy of Graves' hyperthyroidism: Standard vs. calculated 131-I activity. Results of a prospective, randomised, multicentre study
    • 0014-2972
    • H. Peters, C. Fischer, U. Bogner, and H. Schleusener, " Radioiodine therapy of Graves' hyperthyroidism: Standard vs. calculated 131-I activity. Results of a prospective, randomised, multicentre study.," Eur. J. Clin. Invest. 25, 186-193 (1995). 0014-2972
    • (1995) Eur. J. Clin. Invest. , vol.25 , pp. 186-193
    • Peters, H.1    Fischer, C.2    Bogner, U.3    Schleusener, H.4
  • 2
    • 0032875173 scopus 로고    scopus 로고
    • Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: Is more than seven-thousand rad target dose necessary?
    • 1050-7256
    • L. Bajnok, E. Mezosi, E. Nagy, J. Szabo, I. Sztojka, J. Varga, L. Galuska, and A. Leovey, " Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: Is more than seven-thousand rad target dose necessary? " Thyroid 9, 865-869 (1999). 1050-7256
    • (1999) Thyroid , vol.9 , pp. 865-869
    • Bajnok, L.1    Mezosi, E.2    Nagy, E.3    Szabo, J.4    Sztojka, I.5    Varga, J.6    Galuska, L.7    Leovey, A.8
  • 3
    • 0034795484 scopus 로고    scopus 로고
    • Determination of the optimal minimum radioiodine dose in patients with Graves' disease. A clinical outcome study
    • 0340-6997 10.1007/s002590100621.
    • D. Howarth, M. Epstein, L. Lan, P. Tan, and J. Booker, " Determination of the optimal minimum radioiodine dose in patients with Graves' disease. A clinical outcome study.," Eur. J. Nucl. Med. 0340-6997 10.1007/s002590100621 28, 1489-1495 (2001).
    • (2001) Eur. J. Nucl. Med. , vol.28 , pp. 1489-1495
    • Howarth, D.1    Epstein, M.2    Lan, L.3    Tan, P.4    Booker, J.5
  • 4
    • 0036366552 scopus 로고    scopus 로고
    • Radioiodine therapy in Graves' disease based on tissue absorbed dose calculations: Effect of pre-treatment thyroid volume on clinical outcome
    • 0340-6997
    • M. J. Reinhardt, I. Brink, A. Y. Joe, D. von Mallek, S. Ezziddin, H. Palmedo, and T. M. Krause, " Radioiodine therapy in Graves' disease based on tissue absorbed dose calculations: Effect of pre-treatment thyroid volume on clinical outcome.," Eur. J. Nucl. Med. 29, 1118-1124 (2002). 0340-6997
    • (2002) Eur. J. Nucl. Med. , vol.29 , pp. 1118-1124
    • Reinhardt, M.J.1    Brink, I.2    Joe, A.Y.3    Von Mallek, D.4    Ezziddin, S.5    Palmedo, H.6    Krause, T.M.7
  • 5
    • 85027228313 scopus 로고    scopus 로고
    • Council Directive 97/43/EURATOM on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, and repealing directive 84/466/EURATOM (June).
    • Council Directive 97/43/EURATOM on health protection of individuals against the dangers of ionizing radiation in relation to medical exposure, and repealing directive 84/466/EURATOM (June 1997).
    • (1997)
  • 6
    • 10844220088 scopus 로고    scopus 로고
    • International Commission on Radiation Units and Measurements Report No. 67, (unpublished); (Nuclear Technology, Ashford, England, 2002).
    • International Commission on Radiation Units and Measurements Report No. 67, 2002 (unpublished); Absorbed-Dose Specification in Nuclear Medicine (Nuclear Technology, Ashford, England, 2002).
    • (2002) Absorbed-Dose Specification in Nuclear Medicine
  • 7
    • 1542286684 scopus 로고    scopus 로고
    • Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism
    • 0144-8420 10.1093/rpd/nch013.
    • H. Jönsson and S. Mattsson, " Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism.," Radiat. Prot. Dosim. 0144-8420 10.1093/rpd/nch013 108, 107-114 (2004).
    • (2004) Radiat. Prot. Dosim. , vol.108 , pp. 107-114
    • Jönsson, H.1    Mattsson, S.2
  • 9
    • 0037035397 scopus 로고    scopus 로고
    • A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease
    • 0031-9155 10.1088/0031-9155/47/9/305.
    • F. Di Martino, A. C. Traino, A. B. Brill, M. G. Stabin, and M. Lazzeri, " A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/47/9/305 47, 1493-1499 (2002).
    • (2002) Phys. Med. Biol. , vol.47 , pp. 1493-1499
    • Di Martino, F.1    Traino, A.C.2    Brill, A.B.3    Stabin, M.G.4    Lazzeri, M.5
  • 10
    • 3142695423 scopus 로고    scopus 로고
    • A dosimetric approach to patient specific radioiodine treatment of Graves' disease with incorporation of treatment induced changes in thyroid mass
    • 0094-2405 10.1118/1.1763411.
    • A. C. Traino, F. Di Martino, and M. Lazzeri, " A dosimetric approach to patient specific radioiodine treatment of Graves' disease with incorporation of treatment induced changes in thyroid mass.," Med. Phys. 0094-2405 10.1118/1.1763411 31, 2121-2127 (2004).
    • (2004) Med. Phys. , vol.31 , pp. 2121-2127
    • Traino, A.C.1    Di Martino, F.2    Lazzeri, M.3
  • 11
    • 0026653895 scopus 로고
    • New simple method for thyroid volume determination by ultrasonography
    • 0091-2751 10.1002/jcu.1870200505.
    • A. Szebeni and E. Beleznay, " New simple method for thyroid volume determination by ultrasonography.," J. Clin. Ultrasound 0091-2751 10.1002/jcu.1870200505 20, 329-339 (1992).
    • (1992) J. Clin. Ultrasound , vol.20 , pp. 329-339
    • Szebeni, A.1    Beleznay, E.2
  • 12
    • 39449127301 scopus 로고    scopus 로고
    • Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    • C. Kobe, W. Eschner, F. Sudbrock, I. Weber, K. Marx, M. Dietlein, and H. Schicha, " Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?," Nuklearmedizin 47, 13-17 (2008).
    • (2008) Nuklearmedizin , vol.47 , pp. 13-17
    • Kobe, C.1    Eschner, W.2    Sudbrock, F.3    Weber, I.4    Marx, K.5    Dietlein, M.6    Schicha, H.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.